Skip to main content
In stock|Immunotherapy (Checkpoint Inhibitor)

Penpulimab

Oncology TypeBoth (Solid & Hematologic)
Drug Class / MechanismAnti-PD-1 mAb
No Image
Description

Penpulimab is classified as an Anti-PD-1 mAb, sourced for use within our Immunotherapy (Checkpoint Inhibitor) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryImmunotherapy (Checkpoint Inhibitor)
Oncology TypeBoth (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3